MedTrace Logo

NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study

NCT00595751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2008-07-30

No results posted yet for this study

Summary

The study will evaluate the effectiveness of a standardized EEG method with the intended clinical users in the intended clinical settings with the intended population (patients who would typically receive a clinician's evaluation for ADHD). Multiple sites will be examined to provide a sample of patients across numerous communities with different demographics. The goal is to evaluate if the predictive accuracy of EEG will not be inferior to that of a widely-used and extensively validated ADHD scale in the prediction of ADHD in the intended use population as evaluated by Best Estimate Diagnosis.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Sponsors & Collaborators

  • Lexicor Medical Technology, LLC

    lead INDUSTRY

Principal Investigators

  • Humberto Quintana, MD · LSU, HSC

  • Steve Snyder, Ph.D. · Lexicor Medical Technology, LLC

  • Humberto Quintana, MD · LSU, HSC

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00595751 on ClinicalTrials.gov